Israel Startup Licenses Stanford Institute Metabolites To Develop Weight Loss Supplements

Israeli startup by biomedical researcher and entrepreneur Morris Laster using research from ChEM-H Institute scholar at Stanford to will develop and market compounds as nutraceuticals to offer an effective, affordable and side-effect-free solution for weight loss.

• Source: Shutterstock

More from Deals

More from Biotech